BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16905744)

  • 1. CXCL12 induces tyrosine phosphorylation of cortactin, which plays a role in CXC chemokine receptor 4-mediated extracellular signal-regulated kinase activation and chemotaxis.
    Luo C; Pan H; Mines M; Watson K; Zhang J; Fan GH
    J Biol Chem; 2006 Oct; 281(40):30081-93. PubMed ID: 16905744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine CXCL12 induces binding of ferritin heavy chain to the chemokine receptor CXCR4, alters CXCR4 signaling, and induces phosphorylation and nuclear translocation of ferritin heavy chain.
    Li R; Luo C; Mines M; Zhang J; Fan GH
    J Biol Chem; 2006 Dec; 281(49):37616-27. PubMed ID: 17056593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of CXCR4-mediated T-cell chemotaxis and mitogen-activated protein kinase activation by the membrane tyrosine phosphatase, CD45.
    Fernandis AZ; Cherla RP; Ganju RK
    J Biol Chem; 2003 Mar; 278(11):9536-43. PubMed ID: 12519755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL12 activation of CXCR4 regulates mucosal host defense through stimulation of epithelial cell migration and promotion of intestinal barrier integrity.
    Smith JM; Johanesen PA; Wendt MK; Binion DG; Dwinell MB
    Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G316-26. PubMed ID: 15358596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells.
    Fernandis AZ; Prasad A; Band H; Klösel R; Ganju RK
    Oncogene; 2004 Jan; 23(1):157-67. PubMed ID: 14712221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arg kinase mediates CXCL12/CXCR4-induced invadopodia formation and invasion of glioma cells.
    Chen L; Zhu M; Yu S; Hai L; Zhang L; Zhang C; Zhao P; Zhou H; Wang S; Yang X
    Exp Cell Res; 2020 Apr; 389(1):111893. PubMed ID: 32035133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activating and inhibitory Ly49 receptors modulate NK cell chemotaxis to CXC chemokine ligand (CXCL) 10 and CXCL12.
    Inngjerdingen M; Rolstad B; Ryan JC
    J Immunol; 2003 Sep; 171(6):2889-95. PubMed ID: 12960311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plectin regulates the signaling and trafficking of the HIV-1 co-receptor CXCR4 and plays a role in HIV-1 infection.
    Ding Y; Zhang L; Goodwin JS; Wang Z; Liu B; Zhang J; Fan GH
    Exp Cell Res; 2008 Feb; 314(3):590-602. PubMed ID: 18155192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deubiquitination of CXCR4 by USP14 is critical for both CXCL12-induced CXCR4 degradation and chemotaxis but not ERK ativation.
    Mines MA; Goodwin JS; Limbird LE; Cui FF; Fan GH
    J Biol Chem; 2009 Feb; 284(9):5742-52. PubMed ID: 19106094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterologous regulation of chemokine receptor signaling by the lipid phosphatase SHIP in lymphocytes.
    Wain CM; Westwick J; Ward SG
    Cell Signal; 2005 Oct; 17(10):1194-202. PubMed ID: 16038794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXC chemokine ligand 12-induced focal adhesion kinase activation and segregation into membrane domains is modulated by regulator of G protein signaling 1 in pro-B cells.
    Le Y; Honczarenko M; Glodek AM; Ho DK; Silberstein LE
    J Immunol; 2005 Mar; 174(5):2582-90. PubMed ID: 15728464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of the MEK1/2 and AKT pathways in CXCL12/CXCR4 induced cholangiocarcinoma cell invasion.
    Leelawat K; Leelawat S; Narong S; Hongeng S
    World J Gastroenterol; 2007 Mar; 13(10):1561-8. PubMed ID: 17461449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal cell-derived factor-1alpha/CXCL12-induced chemotaxis of T cells involves activation of the RasGAP-associated docking protein p62Dok-1.
    Okabe S; Fukuda S; Kim YJ; Niki M; Pelus LM; Ohyashiki K; Pandolfi PP; Broxmeyer HE
    Blood; 2005 Jan; 105(2):474-80. PubMed ID: 15345598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal cell-derived factor-1 alpha and stem cell factor/kit ligand share signaling pathways in hemopoietic progenitors: a potential mechanism for cooperative induction of chemotaxis.
    Dutt P; Wang JF; Groopman JE
    J Immunol; 1998 Oct; 161(7):3652-8. PubMed ID: 9759889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events.
    Gouwy M; Struyf S; Noppen S; Schutyser E; Springael JY; Parmentier M; Proost P; Van Damme J
    Mol Pharmacol; 2008 Aug; 74(2):485-95. PubMed ID: 18469140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells.
    Kijima T; Maulik G; Ma PC; Tibaldi EV; Turner RE; Rollins B; Sattler M; Johnson BE; Salgia R
    Cancer Res; 2002 Nov; 62(21):6304-11. PubMed ID: 12414661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syndecan-4 is a signaling molecule for stromal cell-derived factor-1 (SDF-1)/ CXCL12.
    Charnaux N; Brule S; Hamon M; Chaigneau T; Saffar L; Prost C; Lievre N; Gattegno L
    FEBS J; 2005 Apr; 272(8):1937-51. PubMed ID: 15819887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the intracellular domains of CXCR4 in SDF-1-mediated signaling.
    Roland J; Murphy BJ; Ahr B; Robert-Hebmann V; Delauzun V; Nye KE; Devaux C; Biard-Piechaczyk M
    Blood; 2003 Jan; 101(2):399-406. PubMed ID: 12393663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma.
    Uchida D; Begum NM; Almofti A; Nakashiro K; Kawamata H; Tateishi Y; Hamakawa H; Yoshida H; Sato M
    Exp Cell Res; 2003 Nov; 290(2):289-302. PubMed ID: 14567988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
    Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M
    J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.